{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:04:01Z","timestamp":1791198241281,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Non-steroidal anti-inflammatory drugs (NSAIDs) vary in their propensity to cause damage in different regions of the gastrointestinal (GI) tract in laboratory animals and humans. This may depend on the type of drug formulation as well as the intrinsic pharmacological properties of the drugs. The purpose of this study was to determine the effects of NSAIDs, with cyclooxygenase 1 and 2 inhibitory activity but with different potency as inhibitors of prostaglandin production, when given orally as tablet\/capsule formulations of NSAIDs for 10 days to pigs, a species that has close resemblance in structure and function of the tract to that in humans. Three capsule or tablet formulations of NSAIDs were given orally to pigs for 10 days. GI bleeding was measured by determination of radioactive iron in the faeces from 59Fe-pre-labelled red blood cells. The blood loss was compared with the pathological changes in the GI mucosa observed at autopsy, mucosal myeloperoxidase (MPO) activity as an index of leucocyte infiltration, and plasma and mucosal concentrations of the drugs at termination assayed by high-performance liquid chromatography. Mucosal damage and bleeding varied according to the type of NSAID. Gastroduodenal ulcers and lesions occurred with the cyclooxygenase inhibitors indometacin (indomethacin) (Indocid capsules 10 or 5 mg kg\u22121 day\u22121 b.i.d.), aspirin (USP tablets 150 mg kg\u22121 day\u22121 b.i.d) and naproxen (Apotex tablets 50 or 75 mg kg\u22121 day\u22121 b.i.d.), and there was an increase in the cumulative (i.e. 10-day) blood loss at higher doses of indometacin and naproxen, and with aspirin. There was no statistically significant increase in gastric or intestinal mucosal MPO activity in the non-damaged mucosa with these drugs and this was confirmed by histological observations in non-lesioned areas of the mucosa. Indometacin produced focal ulcers in the caecum but this was not observed with the other drugs. All the NSAIDs produced significant blood loss coincident with gastric ulceration but no increase in gastric or intestinal MPO activity. Plasma concentrations of the non-aspirin NSAIDs were within the range encountered therapeutically in humans. The mucosal concentrations of indometacin in the gastric and intestinal mucosa correlated with mucosal injury. These findings show that: (i) NSAIDs vary in their propensity to produce mucosal injury in different regions of the GI tract according to their pharmacological properties and formulation; (ii) mucosal injury from some NSAIDs may not directly relate to blood loss at low doses of NSAIDs and this may depend on inhibition of platelet aggregation; and (iii) the occurrence of caecal ulcers uniquely observed with indometacin treatment may be relevant to the development of intestinal pathology (e.g. diaphragm-like strictures) seen occasionally in humans. These results suggest that the pig model employed in the present studies may be useful for investigations of GI damage from NSAID tablets\/capsules, especially in regions that are generally inaccessible to routine endoscopic investigations in humans (e.g. the proximal regions of the large intestine).<\/jats:p>","DOI":"10.1211\/002235703765344577","type":"journal-article","created":{"date-parts":[[2003,6,19]],"date-time":"2003-06-19T04:53:49Z","timestamp":1055998429000},"page":"661-668","source":"Crossref","is-referenced-by-count":43,"title":["Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease"],"prefix":"10.1093","volume":"55","author":[{"given":"K D","family":"Rainsford","sequence":"first","affiliation":[{"name":"Biomedical Research Centre, Sheffield Hallam University , Sheffield, S1 1WB,","place":["UK"]},{"name":"McMaster University Faculty of Health Sciences , Hamilton, Ontario, L8N 3Z5,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P I","family":"Stetsko","sequence":"additional","affiliation":[{"name":"McMaster University Faculty of Health Sciences , Hamilton, Ontario, L8N 3Z5,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Sirko","sequence":"additional","affiliation":[{"name":"McMaster University Faculty of Health Sciences , Hamilton, Ontario, L8N 3Z5,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Debski","sequence":"additional","affiliation":[{"name":"McMaster University Faculty of Health Sciences , Hamilton, Ontario, L8N 3Z5,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,5,1]]},"reference":[{"key":"2024103109400279900_cit1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2036.1994.tb00309.x","article-title":"Ulceration, fibrosis and diaphragmlike lesions in the caecum of rats treated with indomethacin","volume":"8","author":"Anthony","year":"1994","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2024103109400279900_cit2","first-page":"450P","article-title":"Correlations between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment","volume":"67","author":"Billingham","year":"1979","journal-title":"Br. J. Pharmacol."},{"key":"2024103109400279900_cit3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0016-5085(87)90909-7","article-title":"Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans","volume":"93","author":"Bjarnason","year":"1987","journal-title":"Gastroenterology"},{"issue":"Suppl.","key":"2024103109400279900_cit4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365528909091195","article-title":"Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man","volume":"164","author":"Bjarnason","year":"1989","journal-title":"Scand. J. Gastroenterol."},{"key":"2024103109400279900_cit5","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"2024103109400279900_cit6","first-page":"29","article-title":"The enterohepatic circulation of some anti-inflammatory drugs may cause intestinal ulcerations","volume-title":"Side-effects of anti-inflammatory drugs. Pt. 2. Studies in major organ systems","author":"Brune","year":"1987"},{"key":"2024103109400279900_cit7","doi-asserted-by":"crossref","DOI":"10.1126\/science.152.3728.1526","volume-title":"Swine in biomedical research","author":"Bustad","year":"1966"},{"key":"2024103109400279900_cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-011-2982-4_1","article-title":"The gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs","volume-title":"Side-effects of anti-inflammatory drugs","author":"Carson","year":"1992"},{"key":"2024103109400279900_cit9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1211\/0022357011775163","article-title":"Gastrointestinal transit of dosage forms in the pig","volume":"53","author":"Davis","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103109400279900_cit10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/clpt.1982.103","article-title":"Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis","volume":"31","author":"Day","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103109400279900_cit11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0006-2952(75)90450-5","article-title":"Enterohepatic circulation of indomethacin and its role in intestinal irritation","volume":"25","author":"Duggan","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"2024103109400279900_cit12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02735559","article-title":"Intestinal pathology from NSAIDs","volume":"4","author":"Halter","year":"1996","journal-title":"Inflammopharmacology"},{"key":"2024103109400279900_cit13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/978-94-011-2982-4_8","article-title":"The ulcerogenic and anti-haemostatic effects of NSAIDs in the gut","volume-title":"Side-effects of anti-inflammatory drugs","author":"Hawkey","year":"1992"},{"key":"2024103109400279900_cit14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D","article-title":"Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group","volume":"43","author":"Hawkey","year":"2000","journal-title":"Arthritis Rheum."},{"key":"2024103109400279900_cit15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02735556","article-title":"A clinician's view of strategies for preventing NSAID-induced gastrointestinal ulcers","volume":"4","author":"Huang","year":"1996","journal-title":"Inflammopharmacology"},{"key":"2024103109400279900_cit16","first-page":"1455","article-title":"Pathogenesis of porcine gastric ulcers","volume":"28","author":"Huber","year":"1967","journal-title":"Am. J. Vet. Res."},{"key":"2024103109400279900_cit17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/gut.32.1.66","article-title":"Do non-steroidal anti-inflammatory drugs increase colonic permeability","volume":"32","author":"Jenkins","year":"1991","journal-title":"Gut"},{"key":"2024103109400279900_cit18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/26.2.103","article-title":"Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral non-steroidal anti-inflammatory drug therapy","volume":"26","author":"Jenkins","year":"1987","journal-title":"Br. J. Rheumatol."},{"key":"2024103109400279900_cit19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","article-title":"Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models","volume":"87","author":"Krawisz","year":"1984","journal-title":"Gastroenterology"},{"key":"2024103109400279900_cit20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/jcp.41.5.516","article-title":"Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs","volume":"41","author":"Lang","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"2024103109400279900_cit21","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1136\/bmj.290.6465.347","article-title":"Use of anti-inflammatory drug, by patients admitted with small or large bowel perforations and haemorrhage","volume":"290","author":"Langman","year":"1985","journal-title":"Br. Med. J."},{"key":"2024103109400279900_cit22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2165\/00003088-198712060-00002","article-title":"Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs","volume":"12","author":"Lin","year":"1987","journal-title":"Clin. Pharmacokinet."},{"key":"2024103109400279900_cit23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"2024103109400279900_cit24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0140-6736(91)91300-J","article-title":"Enteroscopic diagnosis of small ulceration in patients receiving non-steroidal anti-inflammatory drugs","volume":"337","author":"Morris","year":"1991","journal-title":"Lancet"},{"key":"2024103109400279900_cit25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-94-009-0713-3_9","article-title":"Dual inhibitory effects of azapropazone on both neutrophil migration and function: relation to cardiovascular protection","volume-title":"Azapropazone \u2014 20 years of clinical use","author":"Mousa","year":"1989"},{"key":"2024103109400279900_cit26","first-page":"1455","article-title":"Pathology of gastric ulcers in swine","volume":"28","author":"Muggenburg","year":"1967","journal-title":"Am. J. Vet. Res."},{"key":"2024103109400279900_cit27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0160-5402(85)90029-4","article-title":"Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium","volume":"14","author":"Mullane","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"2024103109400279900_cit28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000658-197208000-00002","article-title":"A swine stress ulcer model","volume":"176","author":"Norton","year":"1972","journal-title":"Ann. Surg."},{"key":"2024103109400279900_cit29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0016-5085(94)90687-4","article-title":"Acute indomethacin induced jejunal injury in the rat: early morphological and biochemical changes","volume":"106","author":"Nygard","year":"1994","journal-title":"Gastroenterology"},{"key":"2024103109400279900_cit30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.2042-7158.1978.tb13181.x","article-title":"Gastric mucosal ulceration induced by tablets but not suspensions or solutions of aspirin in pigs","volume":"30","author":"Rainsford","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103109400279900_cit31","first-page":"148","article-title":"A comparison of the gastroulcerogenic activity of benoxaprofen with other non-steroidal anti-inflammatory drugs in rats and pigs","volume":"5","author":"Rainsford","year":"1982","journal-title":"Eur. J. Rheumatol. Inflamm."},{"key":"2024103109400279900_cit32","first-page":"207","article-title":"Mechanisms of intestinal mucosal damage by non-steroidal anti-inflammatory drugs","volume-title":"Gastroenterology: new trends in pathophysiology and therapy of the large bowel.","author":"Rainsford","year":"1983"},{"key":"2024103109400279900_cit33","first-page":"181","article-title":"Animal models for the assay of gastrointestinal toxicity of anti-inflammatory drugs","volume-title":"Handbook of animal models for the rheumatic disease","author":"Rainsford","year":"1988"},{"key":"2024103109400279900_cit34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/019262338801600308","article-title":"Mucosal lesions induced in rat intestinal tract by the anti-inflammatory drug, Wy 41,770, a weak inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin synthesis inhibitor, indomethacin","volume":"16","author":"Rainsford","year":"1988","journal-title":"Toxicol. Pathol."},{"key":"2024103109400279900_cit35","first-page":"59","article-title":"Mode of action, uses, and side effects of anti-inflammatory drugs","volume-title":"Advances in anti-rheumatic therapy","author":"Rainsford","year":"1996"},{"key":"2024103109400279900_cit36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02674920","article-title":"Gastrointestinal damage and bleeding from non-steroidal anti-inflammatory drugs. 1. Clinical and epidemiological aspects","volume":"3","author":"Rainsford","year":"1995","journal-title":"Inflammopharmacology"},{"key":"2024103109400279900_cit37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF01297219","article-title":"Relationship of gastric mucosal damage induced in pigs by anti-inflammatory drugs to their effects on prostaglandin production","volume":"27","author":"Rainsford","year":"1982","journal-title":"Dig. Dis. Sci."},{"key":"2024103109400279900_cit38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/clpt.1992.41","article-title":"Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers","volume":"51","author":"Rainsford","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"2024103109400279900_cit39","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/BF02285189","article-title":"Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes","volume":"40","author":"Rainsford","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"2024103109400279900_cit40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-109-5-353","article-title":"Non-steroidal anti-inflammatory drugs: gastropathology, deaths and medical practice","volume":"109","author":"Roth","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"2024103109400279900_cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365528708991847","article-title":"Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract","volume":"22","author":"Rampton","year":"1987","journal-title":"Scand. J. Gastroenterol."},{"key":"2024103109400279900_cit42","first-page":"2115","article-title":"Biological fate of glucuronides in the rat. The role of rearrangement, intestinal enzymes and reabsorption","volume":"34","author":"Ruelius","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"2024103109400279900_cit43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"2024103109400279900_cit44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01630479","article-title":"New insights into the mode of action of anti-inflammatory drugs","volume":"44","author":"Vane","year":"1995","journal-title":"Inflamm. Res."},{"key":"2024103109400279900_cit45","first-page":"G462","article-title":"Gastric ulceration induced by non-steroidal anti-inflammatory drugs is a neutrophil-dependent process","volume":"259","author":"Wallace","year":"1990","journal-title":"Am. J. Physiol"},{"key":"2024103109400279900_cit46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002619900282","article-title":"NSAID injury to the small intestine","volume":"23","author":"Zalev","year":"1998","journal-title":"Abdom. Imaging"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F002235703765344577","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/55\/5\/661\/60259958\/002235703765344577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/55\/5\/661\/60259958\/002235703765344577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:15:08Z","timestamp":1730369708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/55\/5\/661\/6148251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2003,5,1]]},"published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.1211\/002235703765344577","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,5]]},"published":{"date-parts":[[2003,5,1]]}}}